Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tenet Healthcare Corporation (THC) vs Global X Uranium ETF (URA) Price & Performance

Tenet Healthcare CorporationTrade
Global X Uranium ETFTrade

Price performance (Past 24H)

Key statistics

Tenet Healthcare Corporation vs Global X Uranium ETF — how do they compare? Tenet Healthcare Corporation trades at $262.03 (market cap $20.98B), while Global X Uranium ETF trades at $38.92 (market cap $5.48B). The key difference: Tenet Healthcare Corporation is far larger — about 3.8× Global X Uranium ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Global X Uranium ETF for 62 Days on average.

THCURA
Market Cap
$20.98B$5.48B
Volume
428,0085,287,170
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$280.77$61.81
52-Week Low
$161.37$37.52
Typical Hold Time
15 Days62 Days
Enterprise Value
$32.06B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $261.07, up 0.48% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 82.83% gross margins and consistent earnings beats, while trading at attractive valuations including a 10.07 P/E ratio. Recent news highlights upcoming Q3 2026 earnings on October 29th and positive coverage of the company's growth prospects despite surgical volume challenges.

THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $283.36 consensus target offering 8.5% upside. The healthcare provider shows improving profitability with net margins expected to reach 9.89% in 2026. Key risks include capital allocation sustainability and potential volatility around upcoming earnings, but the combination of value pricing and growth momentum supports a positive outlook.

Global X Uranium ETF

URA is trading at $38.58, down 3.38% today amid bearish technical signals. The ETF shows negative momentum with all 13 moving averages signaling sell. Recent news highlights nuclear energy's growth potential, including US-Saudi atomic deals and AI-driven power demand, though uranium miners face price volatility. The fund provides diversified exposure to uranium miners, utilities, and nuclear infrastructure companies.

Outlook remains cautiously optimistic given nuclear energy's structural growth drivers, but near-term pressure persists from uranium price fluctuations. Key risks include commodity volatility and regulatory uncertainty, while catalysts include government nuclear investments and AI power demand. The current technical weakness may present entry opportunities for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

THC

No sentiment data available yet.

URA
94% Buy6% Sell
Avg holding period · 62 Days

Top news

Latest headlines on both assets

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →

About Global X Uranium ETF

URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.

Read more on URA →